Possible relationships between changes in body weight set-point and stress metabolism after treating rats chronically with d-fenfluramine
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (8) , 1265-1271
- https://doi.org/10.1016/0006-2952(85)90504-0
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Long‐chain fatty acids and their acyl‐CoA esters cause the translocation of phosphatidate phosphohydrolase from the cytosolic to the microsomal fraction of rat liverFEBS Letters, 1984
- Anorectic agents lower a body weight set pointLife Sciences, 1982
- ALTERED HYPOTHALAMIC AND SYMPATHETIC RESPONSES TO HYPOGLYCAEMIA IN FAMILIAL OBESITYThe Lancet, 1982
- Stimulation of the activities of phosphatidate phosphohydrolase and tyrosine aminotransferase in rat hepatocytes by glucocorticoidsFEBS Letters, 1981
- Tolerance to anorectic drugs: Pharmacological or artifactualPharmacology Biochemistry and Behavior, 1981
- Can the alterations in serum glucocorticoid concentrations explain the effects of ethanol and benfluorex on the synthesis of hepatic triacylglycerols?Journal of Pharmacy and Pharmacology, 1979
- Biochemical pharmacology of the anorectic drug fenfluramine: a reviewCurrent Medical Research and Opinion, 1979
- The mode of action of fenfluramine and its derivatives and their effects on glycerolipid metabolismCurrent Medical Research and Opinion, 1979
- Studies on the ethanol-induced changes in glycerolipid synthesis in rats and their partial reversal by N-(2-benzoyloxyethyl)norfenfluramine (benfluorex)Journal of Pharmacy and Pharmacology, 1977
- Fenfluramine in corticosteroid-induced obesityCurrent Medical Research and Opinion, 1972